02.26.25 -- No Shadow Organizations Needed (Stick To Your Virtual Model)

Rising incidences of dermatological conditions, including acne, psoriasis, and skin cancer, are driving growth in topical drugs. Pharma companies are increasingly using contract manufacturers.

Addressing tablet edge erosion and friability involves adjusting formulation, tablet design, tooling, press setup, and operation speed to improve tablet robustness and reduce weight loss.

To help manage impurities and mitigate risk across all stages of development, consider the benefits of working with a CDMO that has robust chemistry understanding and manufacturing experience.

Explore innovative solutions for improving the solubility and bioavailability of poorly soluble compounds in solid oral dosage forms to enhance drug delivery and therapeutic effectiveness.

Gain insights into a “simul-spray” process pioneering for combining small and large molecules into a single, atomized drug product for inhalation administration.

Here, we look at how one solid dispersion technology lowered patients' pill burdens and demonstrated an improved therapeutic response for Galeterone.

Consider the many advantages of partnering with a CDMO, including their extensive expertise and capabilities across oral solids and specialized nasal and pulmonary formulations.

A partner with experts who are adept at working with complex, sensitive, and potent APIs, screening for the optimal formulation, and scaling up efficiently is vital for successful trials and commercialization.

Our innovative business model doesn't add additional costs to your project. Review our network's regulatory starting material capabilities and contact us to simplify your solutions.